These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7083729)

  • 1. Antiarrhythmic effects of the quaternary propranolol analog that does not induce beta-adrenergic blockade.
    Reele SB; Kornhauser D; Shand D; Carr K; Oates JA; Woosley RL
    Clin Pharmacol Ther; 1982 Jul; 32(1):33-40. PubMed ID: 7083729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of chronic ventricular arrhythmias with propranolol.
    Woosley RL; Kornhauser D; Smith R; Reele S; Higgins SB; Nies AS; Shand DG; Oates JA
    Circulation; 1979 Oct; 60(4):819-27. PubMed ID: 476887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias].
    Ishii M; Komori S; Satoh H; Ohta T; Motomura S; Hashimoto K
    Nihon Yakurigaku Zasshi; 1984 Sep; 84(3):259-66. PubMed ID: 6149986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiarrhythmic activity of meobentine sulfate in man.
    Duff HJ; Oates JA; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1984; 6(4):650-6. PubMed ID: 6206320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
    Lucchesi BR; Kniffen FJ
    Circulation; 1975 Dec; 52(6 Suppl):III241-7. PubMed ID: 1182977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.
    Murray KT; Reilly C; Koshakji RP; Roden DM; Lineberry MD; Wood AJ; Siddoway LA; Barbey JT; Woosley RL
    J Clin Invest; 1990 Mar; 85(3):836-42. PubMed ID: 2155929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias.
    Duff HJ; Roden DM; Yacobi A; Robertson D; Wang T; Maffucci RJ; Oates JA; Woosley RL
    Am J Cardiol; 1985 Feb; 55(4):395-401. PubMed ID: 3969876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.
    Paletta MJ; Abraham S; Beatch GN; Walker MJ
    Br J Pharmacol; 1989 Sep; 98(1):87-94. PubMed ID: 2572292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic blockade and antiarrhythmic activity of (-)- and (+)-propranolol.
    Flórez J; Pomar JL; Malpartida F
    Rev Esp Fisiol; 1969 Dec; 25(4):287-92. PubMed ID: 4401670
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiarrhythmic efficacy of propranolol: comparison of low and high serum concentrations.
    Duff HJ; Mitchell LB; Wyse DG
    J Am Coll Cardiol; 1986 Oct; 8(4):959-65. PubMed ID: 3020109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of pranolium on action potentials of myocardiac cells and on aconitine-induced arrhythmias].
    Liu TF; Wei JH; Wang ZM; Chai Z; Liu XB; Gu XG
    Zhongguo Yao Li Xue Bao; 1985 Dec; 6(4):258-60. PubMed ID: 2945366
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis and pharmacologic properties of pranolium and its optical isomers].
    Foken H; Gerbsch S; Schmauder HP; Heyde R; Lohmann D; Hagen A; Grünheid K; Flöther FU; Gröger D
    Pharmazie; 1990 Mar; 45(3):180-3. PubMed ID: 2381959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents.
    Shalsha KG
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antiarrhythmic activity of the polymeric forms of quinidine, trimecaine, etatsizin, propranolol and verapamil].
    Sidorenko GI; Gurin AV; Koliadko MG; Iurkshtovich TL; Nedorezov VL
    Eksp Klin Farmakol; 1993; 56(3):27-30. PubMed ID: 8219985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and myocardial tissue concentrations of UM-272 (N,N-dimethylpropranolol) after oral administration in dogs.
    Patterson E; Stetson P; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):449-53. PubMed ID: 7391989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic receptor blocking drugs in the treatment of cardiac arrhythmias.
    Theilen EO; Wilson WR
    Med Clin North Am; 1968 Sep; 52(5):1017-29. PubMed ID: 4386418
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual absorption of the quaternary ammonium antiarrhythmic agent, UM-272.
    Patterson E; Stetson P; Lucchesi BR
    Pharmacology; 1983; 27(4):192-6. PubMed ID: 6634932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of pranolium chloride in small mammals.
    Barrow A; Brownsill RD; Spalton PN; Walls CM; Gunn Y; Haskins NJ; Rose DA; Palmer RF
    Xenobiotica; 1980 Mar; 10(3):219-28. PubMed ID: 7467406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.